215 / 1332
30 - 45% develop recurrences within 2 - 3 years Post Rx
Response Evaluation :
Important Predictor for recurrence & survivals
Local Disease :
Response and Detection of Early Local Recurrence
Pelvic and / or Para-aortic Nodal Disease
Other Sites of Distant Metastasis :
Lung, Mediastinal Nodes, Bone,
PET / PET-CT and Cancer Cervix
Post Therapy Surveillance